Free Trial
NASDAQ:BNGO

Bionano Genomics (BNGO) Stock Price, News & Analysis

Bionano Genomics logo
$1.16 0.00 (0.00%)
Closing price 06/15/2026 04:00 PM Eastern
Extended Trading
$1.16 +0.00 (+0.34%)
As of 04:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Bionano Genomics Stock (NASDAQ:BNGO)

Advanced

Key Stats

Today's Range
$1.16
$1.19
50-Day Range
$1.13
$1.33
52-Week Range
$1.06
$5.50
Volume
83,503 shs
Average Volume
153,381 shs
Market Capitalization
$13.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Hold

Company Overview

Bionano Genomics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
53rd Percentile Overall Score

BNGO MarketRank™: 

Bionano Genomics scored higher than 53% of companies evaluated by MarketBeat, and ranked 499th out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bionano Genomics has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

  • Upside Potential

    Bionano Genomics has a consensus price target of $6.00, representing about 417.2% upside from its current price of $1.16.

  • Amount of Analyst Coverage

    Bionano Genomics has only been the subject of 2 research reports in the past 90 days.

  • Read more about Bionano Genomics' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bionano Genomics is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bionano Genomics is -0.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Bionano Genomics has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Bionano Genomics' valuation and earnings.
  • Percentage of Shares Shorted

    9.85% of the float of Bionano Genomics has been sold short.
  • Short Interest Ratio / Days to Cover

    Bionano Genomics has a short interest ratio ("days to cover") of 6.89.
  • Change versus previous month

    Short interest in Bionano Genomics has recently decreased by 8.26%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Bionano Genomics does not currently pay a dividend.

  • Dividend Growth

    Bionano Genomics does not have a long track record of dividend growth.

  • News Sentiment

    Bionano Genomics has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.84 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Bionano Genomics this week, compared to 3 articles on an average week.
  • Search Interest

    2 people have searched for BNGO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Bionano Genomics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bionano Genomics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.65% of the stock of Bionano Genomics is held by insiders.

  • Percentage Held by Institutions

    11.35% of the stock of Bionano Genomics is held by institutions.

  • Read more about Bionano Genomics' insider trading history.
Receive BNGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionano Genomics and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BNGO Stock News Headlines

Bionano Genomics (NASDAQ:BNGO) Upgraded at Wall Street Zen
How to play the Biggest IPO in stock market history!
SpaceX is eyeing a near-$2 trillion IPO valuation, and retail investors are already lining up - but early insiders and institutional holders have been sitting on positions for years and will exit the moment shares hit the market. Lance Ippolito has identified five stocks directly positioned to benefit from the SpaceX launch and the space investing wave it triggers, without the brutal IPO volatility. These picks carry none of the hype risk and all of the tailwind.tc pixel
See More Headlines

BNGO Stock Analysis - Frequently Asked Questions

Bionano Genomics' stock was trading at $1.53 at the start of the year. Since then, BNGO shares have decreased by 24.2% and is now trading at $1.16.

Bionano Genomics, Inc. (NASDAQ:BNGO) released its quarterly earnings results on Wednesday, May, 13th. The company reported ($0.76) earnings per share for the quarter, beating analysts' consensus estimates of ($0.88) by $0.12. The company had revenue of $6.69 million for the quarter, compared to analyst estimates of $6.57 million. Bionano Genomics had a negative net margin of 109.94% and a negative trailing twelve-month return on equity of 71.38%.
Read the conference call transcript
.

Bionano Genomics shares reverse split before market open on Monday, January 27th 2025.The 1-60 reverse split was announced on Wednesday, January 22nd 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, January 24th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Bionano Genomics (BNGO) raised $30 million in an initial public offering (IPO) on Friday, September 21st 2018. The company issued 5,500,000 shares at a price of $5.00-$6.00 per share.

Top institutional investors of Bionano Genomics include Renaissance Technologies LLC (0.44%).
View institutional ownership trends
.

Shares of BNGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bionano Genomics investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), Waste Connections (WCN), AUO (AUOTY), American Water Works (AWK) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/13/2026
Today
6/16/2026
Next Earnings (Estimated)
8/13/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:BNGO
CIK
1411690
Fax
N/A
Employees
300
Year Founded
2002

Price Target and Rating

High Price Target
$6.00
Low Price Target
$6.00
Potential Upside/Downside
+417.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($4.37)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$26.40 million
Net Margins
-109.94%
Pretax Margin
-109.70%
Return on Equity
-71.38%
Return on Assets
-43.07%

Debt

Debt-to-Equity Ratio
0.09
Current Ratio
1.84
Quick Ratio
1.59

Sales & Book Value

Annual Sales
$28.51 million
Price / Sales
0.47
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.37 per share
Price / Book
0.27

Miscellaneous

Outstanding Shares
11,480,000
Free Float
11,400,000
Market Cap
$13.32 million
Optionable
No Data
Beta
1.65

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:BNGO) was last updated on 6/16/2026 by MarketBeat.com Staff.
From Our Partners